ADVFN - Advanced Financial Network.
HOME» NYSE » M » MRK Stock Price » MRK Stock News

Merck Share News

 Merck & Co., Stock Price
MRK Stock Price
 Merck & Co., Stock Chart
MRK Stock Chart
 Merck & Co., Stock News
MRK Stock News
 Merck & Co., Company Information
MRK Company Information
 Merck & Co., Stock Trades
MRK Stock Trades

Applications Given Early Antitrust Clearance

The Hart-Scott-Rodino Act requires under certain circumstances that prospective acquirers of voting securities or assets apply for clearance from regulators. Requests for early termination or clearance are granted when the Federal Trade Commission and the antitrust division of the Department of Justice have determined that they won't take action during the waiting period. The following is a list of companies or people to which the FTC has granted early clearance of antitrust concerns under the HSR Act: NAME OF ACQUIRING PERSON NAME OF ACQUIRED PERSON DATE NAME OF ACQUIRED ENTITY TERMINATED _____________________________________________________________ University of Rochester Friday F.F. Thompson Health System, Inc. F.F. Thompson Health System, Inc. Galaxie Corporation Friday Prospect Capital Corporation Prospect Capital Corporation Prospect Capital Corporation Friday Galaxie Corporation First Tower Corporation Capitol Street Corp. Tower Auto Loan, Inc. Gulfco of Alabama, Inc. Gulfco of Mississippi, Inc. Gulfco of Louisiana, Inc. First Tower Loan, Inc. Tower Loan of Missouri, Inc. Tower Loan of Mississippi, Inc. Welsh, Carson, Anderson & Stowe XI, L.P. Friday NEW Asurion Corporation NEW Asurion Corporation John D. Grier Friday Royal Dutch Shell plc Shell Pipeline Company LP Equilon Enterprises LLC dba Shell Oil Products USA Shell GOM Pipeline Company LLC SAP AG Friday Richard W. Padula Syclo, L.L.C. Merck & Co., Inc. Friday Endocyte, Inc. Endocyte, Inc. Gores Capital Partners III, L.P. Friday TE Connectivity Ltd. TE Connectivity Ltd. Order free Annual Report for Merck & Co., Inc. Visit or call 1-888-301-0513 Order free Annual Report for SAP AG Visit or call 1-888-301-0513

Stock News for Merck (MRK)
11/25/201508:00:07How Big Could This Drug Be for Opko Health?
11/24/201512:35:00Merck Announces Increased Quarterly Dividend
11/24/201507:41:03This Metric Implies That It Might Be Time to Buy Big Pharma Stocks
11/23/201510:01:03Can Merck & Co. Take Down Gilead Sciences?
11/22/201509:12:02Beyond Chemotherapy: 4 Unique Ways Drug Developers Are Fighting...
11/21/201516:30:00Merck Announces Initial Results for KEYTRUDA® (pembrolizumab...
11/21/201509:04:08Gilead Sciences Inc. Has Plenty of Room to Run in Hepatitis C
11/20/201517:55:00Celldex Vaccine Rindopepimut Cuts Death Risk From Brain Cancer...
11/20/201507:40:02Merck & Co.'s Cholesterol-Buster Program Isn't (Yet) an Exercise...
11/19/201506:30:00Lilly and Merck Expand Immuno-oncology Collaboration with Phase...
11/18/201510:18:035 Things Merck & Co., Inc. Wants You to Know
11/17/201515:52:03Why Novavax Inc Is Moving Higher Today
11/17/201510:59:02Here's Why Advaxis' Stock Gained 11% in October
11/17/201508:00:00New Studies Investigating the Use of KEYTRUDA® (pembrolizumab...
11/16/201509:19:033 High-Yield Dividend Stocks You Don't Have to Babysit
11/16/201508:30:00Merck Announces Presentation of Results from Two Phase 2 Studies...
11/15/201518:00:03Exelixis, Inc. Earnings: Riding the Meteor
11/14/201519:00:00Merck Announces Presentation of Phase 3 Results of Investigational...
11/14/201519:00:00Merck to Release Findings from Integrated Analysis of Six Phase...
11/13/201508:41:03Hepatitis C Treatment in 2016: Will Gilead Sciences or AbbVie...

Merck and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations